As Johnson & Johnson's pharmaceuticals arm opened a nearly 200,000-square-foot Peninsula facility last fall, the message from site headwas about efficiently going after new gene therapies and infectious diseases. Now the company is reportedly targeting job cuts, integration and winding down programs.
Heaton wouldn't say at a town hall meeting Wednesday how many jobs would be affected by the changes, Fierce Pharma said. J&J's changes, however, also highlight how corporate-level shifts within Big Biopharmas — whose large space grabs in the Bay Area have helped fuel a biotech real estate boom — can quickly reshape local initiatives and job counts. J&J, which has long held space throughout the Bay Area,of Healthpeak Properties Inc.'s The Shore at Sierra Point complex in Brisbane.
"As we colocate, we can articulate problems more clearly, look at problems differently, to come up with some pretty unique solutions," Merson said at the time."This will allow us to discover, develop and deliver medicines more rapidly than we have in the past."